TeraRecon Launches EnvoyAI Distributorship To Resell The 35+ Algorithms On The EnvoyAI Exchange, Initially Promoting FDA-Cleared Imbio And Icometrix Solutions

Chicago, IL – November 27, 2017: Advanced Visualization solution provider, TeraRecon (WWW.TERARECON.COM) today announced a distribution partnership with EnvoyAI to sell and market the EnvoyAI platform. The platform includes the most content-rich artificial intelligence marketplace, called the En...

Imbio And GE Healthcare Collaborate To Enable Lung Density Analysis™ Within GE Health Cloud Ecosystem

Imbio And GE Healthcare To Support More Personalized CT Lung Diagnosis With Quantifiable Clinical Insights

MINNEAPOLIS, March 21, 2016 /PRNewswire/ -- Imbio, a leader in fully automated, biomarker-based solutions for quantitative Lung imaging, and GE Healthcare are pleased to announce a collaboration to make Imbio’s Lung Density AnalysisTM, a volumetric imaging solution for Lung CT, one of the first so...

Imbio Named Finalist For 16th Annual TEKNE Awards

MHTA To Honor Minnesota’s Top Technology Companies And Individuals At Annual Awards Ceremony

MINNEAPOLIS, Minnesota - The Minnesota High Tech Association (MHTA) has named Imbio as a finalist in the Healthcare – Small & Growing category for the 2015 Tekne Awards, which will be held at the Minneapolis Convention Center on Thursday, Nov. 18. The Tekne Awards honor Minnesota companies and ind...

IMBIO’S CT LUNG ANALYSIS SOFTWARE RECEIVES 510(K) CLEARANCE FROM FDA

Image Processing Software Quantifies Extent Of Lung Tissue Damage In COPD

MINNEAPOLIS, Minnesota—Imbio, LLC, a medical image processing software company, has received FDA 510(k) clearance for their Lung Density Analysis software application, developed in collaboration with medical researchers at the University of Michigan.

COPD (Chronic Obstructive Pulmonary Disease)...